Evidence map›Paper›PMID 30059632›Full record

ArticleAnnals of the American Thoracic Society2018

Nicotine Dependence: Future Opportunities and Emerging Clinical Challenges.

Frank T Leone, Stephen R Baldassarri, Panagis Galiatsatos, Robert Schnoll

Abstract read
In one paragraph

Article in Annals of the American Thoracic Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Tobacco Use Disorder.The Medical clinics of North America · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. The Ontario Pharmacy Evidence Network Atlas of Smoking Cessation Services.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Frank T Leone1 Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Stephen R Baldassarri2 Yale School of Medicine, Yale University, New Haven, Connecticut; and.
Panagis Galiatsatos3 Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Robert Schnoll1 Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SHELLEY L BERGER · 1985 to 2026
$222.3M
Yale Drug use, Addiction and HIV Research Scholars (DAHRS)K12DA033312 · NIDA · YALE UNIVERSITY · PI Gail D'Onofrio, Patrick O'Connor · 2013 to 2026
$7.2M
NCI NIH HHS P30 CA016520NIDA NIH HHS K12 DA033312
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Smoking CessationTobacco Use DisorderBehavior, AddictiveGanglionic StimulantsHumansNicotineRecurrenceTobacco Use Cessation DevicesGanglionic StimulantsNicotineaddictionnicotinesmoking cessationtobacco dependencetobacco use treatment

Identifiers

PMID30059632
PMCPMC6321992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.